Bio-Rad Laboratories Class B
BIO.B
7 hedge funds and large institutions have $1.25M invested in Bio-Rad Laboratories Class B in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.
17% more funds holding
Funds holding: 6 → 7 (+1)
0.01% less ownership
Funds ownership: 0.09% → 0.07% (-0.01%)
10% less capital invested
Capital invested by funds: $1.39M → $1.25M (-$142K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jones Financial Companies
Des Peres,
Missouri
|
+$10.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$239K |
| 2 |
CL
CSS LLC
Chicago,
Illinois
|
-$1.32K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $625K | -$1.32K | -4 | -0.2% |
|
|
BSW
2
Buckingham Strategic Wealth
Clayton,
Missouri
| $259K | – | – | – |
|
|
3
Morgan Stanley
New York
| $247K | -$239K | -724 | -50% |
|
4
Wells Fargo
San Francisco,
California
| $56.5K | – | – | – |
|
|
WT
5
Whittier Trust
South Pasadena,
California
| $52.3K | – | – | – |
|
|
6
Jones Financial Companies
Des Peres,
Missouri
| $11.5K | +$10.9K | +33 | New |
|
|
JFA
7
JNBA Financial Advisors
Bloomington,
Minnesota
| $682 | – | – | – |
|
BIO.B Hedge Fund Activity: Q1 2024 in Review
7 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q1 2024, worth a combined $1.25M — down 10% from $1.39M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BIO.B positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Jones Financial Companies, opening a new position worth an estimated $10.9K. The largest seller was Morgan Stanley, cutting an estimated $239K.
- 7 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q1 2024, up from 6 in Q4 2023.
- Funds reported $1.25M of Bio-Rad Laboratories Class B stock for Q1 2024, down 10% quarter-over-quarter.
- 1 fund opened new Bio-Rad Laboratories Class B positions in Q1 2024 and 0 closed out, a net change of +1 holder.
- The largest Bio-Rad Laboratories Class B buyer in Q1 2024 was Jones Financial Companies, an estimated $10.9K added.
- The largest Bio-Rad Laboratories Class B seller in Q1 2024 was Morgan Stanley, an estimated $239K sold.
Based on aggregated 13F filings for Q1 2024.